Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

BARCELONA, Spain--(BUSINESS WIRE)--Mar 31, 2025--

The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by the pharmaceutical company Ferrer, gathered over 150 experts in pulmonology and cardiology from more than 30 countries in Barcelona this past weekend. The event reaffirmed the clinical community’s commitment to multidisciplinary and international collaboration to improve the treatment of pulmonary hypertension (PH), a serious condition affecting 1% of the population. PH is often accompanied by debilitating symptoms and an increased risk of mortality.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250331514736/en/

Experts have outlined key priorities in addressing pulmonary hypertension. Claudia Valenzuela, pulmonologist at the Interstitial Lung Disease Unit of the Pulmonology Department at Hospital Universitario La Princesa in Madrid, emphasized the need for a comprehensive approach involving various healthcare professionals: “A multidisciplinary approach facilitates accurate diagnosis and timely management of patients. In the case of pulmonary hypertension, we also face the challenge of referring these patients to specialized centers so they can receive a correct diagnosis and comprehensive care.”

Meanwhile, Roberto Badagliacca, professor at the Department of Cardiovascular and Respiratory Sciences at Sapienza University of Rome, highlighted the importance of early diagnosis, stating that “pulmonary hypertension is a degenerative disease, and the earlier it is diagnosed, the sooner specific treatment can begin.”

David Ferrando, Chief Marketing & Market Access Officer at Ferrer, commented, “With this seventh IMPAHCT, we reaffirm Ferrer’s commitment to healthcare professionals in transforming the lives of those affected by pulmonary hypertension, as well as their families and caregivers. In line with our purpose of using business to fight for social justice, we work to provide transformative therapeutic solutions for rare or low-prevalence diseases.”

Additionally, Jorge Cuneo, Chief Medical Officer at Ferrer, stated, “Through continuous training, research, and the exchange of best practices, we aim to drive innovative solutions that make a real difference in the treatment of such a complex and limiting disease. In this regard, collaboration with healthcare professionals is essential to improving daily clinical practice, ultimately resulting in a positive impact on patients.”

The IMPAHCT has established itself as an internationally recognized event in the field of pulmonary hypertension, providing a space for knowledge exchange and updates on the latest therapeutic advances.

David Ferrando, Ferrer's Chief Marketing and Market Access Officer and Jorge Cuneo, Ferrer's Chief Medical Officer, at the IMPAHCT opening session.

MELBOURNE, Australia (AP) — Repeated concussions have taken such a toll on Will Pucovski’s promising cricket career that he’s decided he’ll never play the game again.

Pucovski was a precocious talent when he was first selected for an Australia squad in 2019 but he only played one test match — scoring a flourishing 62 on debut against India in 2021 — because of a string of concussion setbacks.

After taking medical advice to retire from first-class cricket last year following a concussion — reportedly his 13th — in a Sheffield Shield match, the 27-year-old batter confirmed in a radio interview Tuesday that he can't play again at any level because of the toll on his physical and mental health.

“The simple message is, I won’t be playing at any level again," Pucovski told the SEN network. "In the couple of months post that (last concussion) I struggled to get anything done, walking around the house was a struggle ... I was sleeping a lot. The first few months were horrendous, but things didn’t leave me.

“From there it’s been a tough year, a lot of the symptoms didn’t go away, which has led me to this decision."

Pucovski was one of the best batters in Australia but didn’t make his test debut until he faced India at Sydney in January 2021, posting a half-century in his first innings but then dislocating his right shoulder in a fielding mishap. He needed surgery and was ruled out for six months.

After returning to training in October, 2021, he sustained another concussion while batting and was ruled out of cricket for several months again.

He finished his career with a first-class average of 45.19, including seven centuries and a highest score of 255 not out, as well as the record for the highest opening partnership in Australia's domestic first-class competition, the Sheffield Shield.

AP cricket: https://apnews.com/hub/cricket

FILE - Australia's Will Pucovski walks from the field after he was dismissed during play on day three of the third cricket test between India and Australia at the Sydney Cricket Ground, Sydney, Australia, Jan. 9, 2021. (AP Photo/Rick Rycroft, File)